One thing that stood out researching this, getting a medication to show muscle gains on paper isn't especially difficult, but demonstrating a genuine boost in strength or physical function is far rarer and harder to prove. This mostly comes up in contexts treating age or disease-related muscle loss, where the gains are typically only a few percent anyway. Not entirely convinced this concern even applies the same way to muscle loss during GLP-1 use, where part of the benefit likely comes from a higher proportion of lean mass boosting metabolism and supporting long-term weight maintenance. Hard to believe that meaningfully reducing muscle loss in this context wouldn't also translate to better physical performance.